COVID-19 has accelerated a number of 'mega' consumer trends and halted others, according to the strategic market insight provider Euromonitor International, providing insight into how consumers' shopping habits are being shaped in the short...
CBD specialist Elixinol Global has managed to hit its capital raising target of AUD$11m (US$7.3m) following a two-stage fund raising exercise, which it believes is a proof of how its CBD supplements have resonated with its investors.
Increasing interest in digital health solutions is being driven by consumers' need for convenience, lack of faith in pharmaceuticals, and their desire for exercise that can be easily integrated into their lifestyles, according to a new survey by...
Several high-profile lawsuits challenging the legal status of CBD products have been stayed (effectively put on ice until the FDA outlines a regulatory path forward for CBD in foods & supplements) or voluntarily dismissed in recent weeks.
The National Advertising Division has ruled that GSK must stop calling some of its Benefiber prebiotic supplements ‘100% natural.’ It’s a ruling that could be viewed as troublesome for other prebiotic ingredients.
A new stakeholder group has come together to push for quality and transparency in the dietary supplement industry. Called the Dietary Supplement Quality Collaborative (DSQC), the group published a policy paper recently as part of its public debut.
Both local Chinese and foreign infant nutrition brands in China are urged to “push hard on safety cues and messages” in light of the recent infant nutrition scandal happening in the country, according to an industry expert.
Canada's Aurora Cannabis Inc. just announced it will acquire American hemp retailer Reliva LLC. The duo expects to be positioned as a meaningful player in the United States, the world’s largest cannabinoid market.